Retour
55
31
38
Également cotée sous
NVSEF
OTC
Fourchette du Jour
146,93 €
149,15 €
Fourchette 52 Semaines
97,72 €
170,46 €
Volume
1 563 123
Moyenne 50J / 200J
154,83 €
/
133,11 €
Clôture Précédente
146,03 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 20,4 | 0,4 |
| P/B | 6,2 | 2,9 |
| ROE % | 31,2 | 3,8 |
| Net Margin % | 25,6 | 3,9 |
| Rev Growth 5Y % | 5,7 | 10,0 |
| D/E | 0,8 | 0,2 |
Objectif de Cours des Analystes
Hold
127,00 €
-14.2%
Low: 112,00 €
High: 143,00 €
P/E Prévisionnel
16,8
BPA Prévisionnel
8,81 €
Croissance BPA (est.)
+0,0%
CA Est.
57 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
12,56 €
12,04 € – 13,08 €
|
69 B | 6 |
| FY2029 |
11,54 €
11,06 € – 12,02 €
|
66 B | 6 |
| FY2028 |
10,63 €
10,19 € – 11,07 €
|
64 B | 7 |
Points Clés
Revenue grew 5,66% annually over 5 years — modest growth
Earnings grew 17,71% over the past year
ROE of 31,17% indicates high profitability
Net margin of 25,64% shows strong profitability
Generating 17,69B in free cash flow
PEG of 0,85 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
5,66%
Revenue (1Y)5,97%
Earnings (1Y)17,71%
FCF Growth (3Y)22,92%
Qualité
Return on Equity
31,17%
ROIC15,40%
Net Margin25,64%
Op. Margin31,15%
Sécurité
Debt / Equity
0,80
Current Ratio1,12
Interest Coverage14,38
Valorisation
P/E Ratio
20,37
P/B Ratio6,21
EV/EBITDA18,27
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,97% | Revenue Growth (3Y) | 8,38% |
| Earnings Growth (1Y) | 17,71% | Earnings Growth (3Y) | -2,71% |
| Revenue Growth (5Y) | 5,66% | Earnings Growth (5Y) | -12,54% |
| Profitability | |||
| Revenue (TTM) | 54,81B | Net Income (TTM) | 14,06B |
| ROE | 31,17% | ROA | 12,16% |
| Gross Margin | 75,02% | Operating Margin | 31,15% |
| Net Margin | 25,64% | Free Cash Flow (TTM) | 17,69B |
| ROIC | 15,40% | FCF Growth (3Y) | 22,92% |
| Safety | |||
| Debt / Equity | 0,80 | Current Ratio | 1,12 |
| Interest Coverage | 14,38 | Dividend Yield | 0,03% |
| Valuation | |||
| P/E Ratio | 20,37 | P/B Ratio | 6,21 |
| P/S Ratio | 5,22 | PEG Ratio | 0,85 |
| EV/EBITDA | 18,27 | Dividend Yield | 0,03% |
| Market Cap | 286,27B | Enterprise Value | 311,87B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 54,81B | 51,72B | 46,66B | 43,46B | 43,97B |
| Net Income | 14,06B | 11,94B | 14,85B | 6,96B | 24,02B |
| EPS (Diluted) | 7,19 | 5,87 | 7,10 | 3,17 | 10,63 |
| Gross Profit | 41,12B | 38,90B | 34,19B | 31,88B | 32,24B |
| Operating Income | 17,07B | 14,54B | 9,77B | 7,95B | 10,06B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 115,57B | 102,25B | 99,95B | 117,45B | 131,80B |
| Total Liabilities | 69,02B | 58,12B | 53,20B | 58,03B | 63,97B |
| Shareholders' Equity | 46,13B | 44,05B | 46,67B | 59,34B | 67,66B |
| Total Debt | 37,03B | 31,26B | 26,35B | 27,91B | 31,03B |
| Cash & Equivalents | 11,44B | 11,46B | 13,39B | 7,52B | 12,41B |
| Current Assets | 30,46B | 29,70B | 30,48B | 36,91B | 45,72B |
| Current Liabilities | 27,28B | 28,69B | 26,39B | 28,66B | 30,21B |
Scores de Stratégies
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#301 of 1024
Custom
Capital Light Compounder
#151 of 213
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#255 of 326
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Capital Light Compounder
Mar 24, 2026
Entré
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026